RE:Oh ya and then there's Ronnie Ronnie Ronnie"Littlefinger is exactly right that Ronnie is an just a glorified administrator not a builder of companies." Ronnie was the President and CEO of Roche Canada for 22 years. How many drugs was he ultimately responsible for launching in Canada over 22 years? How big of a sales force? How big did he build Roche Canada over 22 years? He managed the national sales force in the UK. He was a product manager in Switzerland and headed up a global sales launch. He pioneered global operating models at Roche which became the largest biotech company in the world. He's been plugged into Canada's biotech ecosystem as Chairman of the Board of Innovative Medicine's Canada which represents the industry and supports innovation. He attracted a $500 million investment in Roche to manage its global technical operations in Ontario. Ronnie knows best practices in biotech.
News release:
"In his 22-year tenure in this role, he was responsible for the growth and success of the Canadian Pharmaceuticals Division, particularly as it relates to Roche’s mandate of developing and delivering innovative healthcare solutions for Canadians. Prior to his appointment as President and CEO, Mr. Miller advanced through a series of successive sales and management positions across the industry to become the National Sales Manager for Roche in the United Kingdom in 1988 and continued to move globally as a Product Manager in Switzerland and Deputy Divisional Director of the Pharmaceutical Division in Japan. He moved back to Switzerland to head up a global product launch before returning to the UK as Pharmaceuticals Director.
In addition to managing Roche Canada where he pioneered global operating models, Mr. Miller was heavily involved in the Canadian Healthcare Ecosystem. He was re-elected as Chairman of the Board of Directors of Innovative Medicines Canada (IMC), the national association representing Canada’s research-based pharmaceutical companies, from 2019 to 2022. Additionally, he served as Chairman of the IMC Board in 2007 and has since fulfilled two subsequent terms as Past Chair. Prior to this, Mr. Miller was the Chair of the IMC Prairies Core Team and sat as Co-Chair of the Health Research Foundation. He also served on several committees including the IMC Public Affairs, Stakeholder Relations, the British Columbia Sub-Committee, and was Chair of the Federal Affairs/FPT Relations Standing Committee.
Over the course of his career some of his major accomplishments include, managing to get the Montreal Heart Institute designated as the hub for translational medicine studying cardiometabolic disease in the global network of Roche International; launching the National Artificial Intelligence Centre of Excellence to drive digital intelligence in Health in 2020; and convincing Swiss Parent Company Hoffmann-La Roche to locate its Global Pharma Technical Operations in Mississauga, Ontario; a $500 million investment."